The University of Chicago Header Logo

Joseph Caprini

Concepts (551)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Venous Thromboembolism
49
2024
178
12.470
Why?
Venous Thrombosis
54
2021
265
7.330
Why?
Anticoagulants
56
2024
486
5.550
Why?
Risk Assessment
47
2024
2604
3.580
Why?
Pulmonary Embolism
30
2024
235
3.130
Why?
Thrombosis
17
2024
319
2.960
Why?
Thromboembolism
28
2020
123
2.160
Why?
Postoperative Complications
46
2023
2719
2.110
Why?
Fibrinolytic Agents
17
2020
244
1.670
Why?
Intermittent Pneumatic Compression Devices
9
2021
11
1.670
Why?
Arthroplasty, Replacement, Hip
8
2023
112
1.500
Why?
Orthopedic Procedures
9
2020
163
1.390
Why?
Risk Factors
56
2024
6295
1.350
Why?
Stockings, Compression
5
2019
6
1.330
Why?
Heparin, Low-Molecular-Weight
13
2021
33
1.280
Why?
Hemorrhage
22
2022
297
1.280
Why?
Orthopedics
5
2020
143
1.190
Why?
Humans
197
2024
98799
1.030
Why?
Neoplasms
17
2023
3382
0.900
Why?
Lower Extremity
5
2023
112
0.830
Why?
Benzimidazoles
5
2012
120
0.820
Why?
Venous Insufficiency
7
2016
13
0.790
Why?
Vascular Diseases
3
2015
119
0.790
Why?
Practice Guidelines as Topic
14
2020
1116
0.770
Why?
Pyridines
5
2012
317
0.750
Why?
Edema
2
2015
68
0.750
Why?
Thoracic Surgical Procedures
1
2023
68
0.710
Why?
Arthroplasty
2
2019
40
0.690
Why?
Arthroplasty, Replacement, Knee
4
2012
122
0.680
Why?
Blood Coagulation
22
2014
90
0.680
Why?
Femoral Vein
3
2021
43
0.680
Why?
Thrombelastography
23
1995
48
0.670
Why?
Predictive Value of Tests
8
2021
1792
0.660
Why?
Blood Flow Velocity
2
2021
181
0.640
Why?
Perioperative Care
4
2020
199
0.610
Why?
Incidence
15
2020
1798
0.600
Why?
Warfarin
10
2015
109
0.590
Why?
Abdomen
4
2008
121
0.580
Why?
Guideline Adherence
6
2016
251
0.580
Why?
Bandages
11
2014
43
0.550
Why?
Veins
5
2016
88
0.550
Why?
Thrombophlebitis
11
2020
24
0.540
Why?
Middle Aged
59
2021
29642
0.510
Why?
Fractures, Bone
1
2019
164
0.510
Why?
Male
68
2021
47475
0.500
Why?
Language
2
2020
165
0.500
Why?
Female
79
2023
51997
0.500
Why?
Platelet Aggregation Inhibitors
2
2020
194
0.500
Why?
Aged
53
2021
21986
0.490
Why?
Leg
9
2022
145
0.490
Why?
Compression Bandages
2
2020
6
0.490
Why?
Heparin
21
2007
182
0.490
Why?
Ultrasonography, Doppler, Duplex
8
2021
42
0.480
Why?
Enoxaparin
5
2010
27
0.480
Why?
Thrombophilia
4
2020
23
0.470
Why?
Registries
10
2020
1133
0.420
Why?
Foot Injuries
1
2014
13
0.420
Why?
Ankle Injuries
1
2014
37
0.410
Why?
Dabigatran
7
2020
25
0.410
Why?
Aspirin
3
2012
168
0.410
Why?
Severity of Illness Index
8
2018
2025
0.400
Why?
Administration, Oral
9
2019
677
0.370
Why?
Aged, 80 and over
20
2021
7461
0.370
Why?
Practice Patterns, Physicians'
3
2009
669
0.360
Why?
Postoperative Hemorrhage
1
2012
55
0.340
Why?
Cholecystectomy, Laparoscopic
5
1997
53
0.340
Why?
Thrombin
3
2008
60
0.340
Why?
Preventive Health Services
2
2010
38
0.340
Why?
Health Knowledge, Attitudes, Practice
4
2013
608
0.330
Why?
Sclerotherapy
2
2023
20
0.330
Why?
Contraindications
5
2023
66
0.330
Why?
Varicose Veins
2
2022
12
0.320
Why?
Fibrin Fibrinogen Degradation Products
8
2021
31
0.310
Why?
Homocysteine
2
2007
31
0.310
Why?
Hyperhomocysteinemia
2
2007
11
0.310
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2012
255
0.310
Why?
Surgical Procedures, Operative
5
2019
236
0.300
Why?
Counterpulsation
1
2009
21
0.300
Why?
Equipment Design
2
2010
428
0.300
Why?
Retrospective Studies
15
2023
11104
0.300
Why?
General Surgery
5
2015
271
0.300
Why?
Blood Transfusion
2
2020
179
0.290
Why?
Drugs, Investigational
1
2009
36
0.290
Why?
Adult
43
2023
29698
0.290
Why?
Blood Coagulation Disorders
9
1995
66
0.290
Why?
Patient Discharge
4
2011
385
0.280
Why?
Travel
3
2009
80
0.280
Why?
Atrial Fibrillation
3
2020
463
0.270
Why?
Evidence-Based Medicine
9
2020
483
0.270
Why?
Prothrombin
4
2005
19
0.270
Why?
Laparotomy
1
2008
65
0.270
Why?
Elective Surgical Procedures
3
2020
178
0.250
Why?
Betacoronavirus
2
2020
288
0.240
Why?
Treatment Outcome
22
2020
9806
0.240
Why?
Factor Xa Inhibitors
4
2020
24
0.230
Why?
Gravity Suits
3
2001
3
0.220
Why?
Disease Management
3
2023
378
0.220
Why?
Pneumonia, Viral
2
2020
343
0.210
Why?
Drug Administration Schedule
6
2020
837
0.210
Why?
Coronavirus Infections
2
2020
339
0.210
Why?
Prospective Studies
15
2022
4837
0.210
Why?
Attitude of Health Personnel
4
2010
688
0.210
Why?
Ultrasonography
5
2018
722
0.200
Why?
United States
15
2018
8387
0.200
Why?
Pandemics
2
2020
923
0.200
Why?
Surveys and Questionnaires
7
2020
3058
0.200
Why?
Rivaroxaban
2
2020
11
0.200
Why?
Hospitalization
3
2021
993
0.190
Why?
Embolism
1
2023
33
0.190
Why?
Postthrombotic Syndrome
2
2014
3
0.190
Why?
Postoperative Care
6
2019
239
0.190
Why?
Time Factors
15
2020
5586
0.180
Why?
Pyridones
2
2020
74
0.180
Why?
Biomarkers
5
2020
2026
0.180
Why?
Pyrazoles
2
2020
162
0.180
Why?
Psychometrics
1
2003
359
0.180
Why?
Cost of Illness
1
2003
165
0.170
Why?
Recurrence
7
2017
1274
0.170
Why?
Lymphatic Diseases
2
2020
31
0.170
Why?
Premedication
2
2017
57
0.170
Why?
Russia
1
2021
29
0.170
Why?
Aerospace Medicine
1
2001
17
0.170
Why?
Quality of Life
4
2014
1904
0.160
Why?
Fibrinolysis
5
1995
35
0.160
Why?
Perioperative Period
2
2017
31
0.160
Why?
Health Care Costs
1
2003
269
0.160
Why?
Monitoring, Physiologic
4
2006
265
0.160
Why?
Risk Adjustment
1
2020
45
0.160
Why?
Saphenous Vein
2
2019
61
0.160
Why?
Injections, Subcutaneous
5
2010
142
0.160
Why?
Wearable Electronic Devices
1
2021
47
0.160
Why?
Blood Loss, Surgical
1
2020
140
0.150
Why?
Communication
1
2023
457
0.150
Why?
Pilot Projects
4
2017
978
0.150
Why?
Clinical Trials as Topic
11
2020
1128
0.140
Why?
Phlebography
2
2018
74
0.140
Why?
Coronary Artery Bypass
1
2001
234
0.140
Why?
Vascular Surgical Procedures
2
2019
173
0.140
Why?
Mass Screening
3
2010
753
0.140
Why?
Peptide Fragments
2
2003
480
0.140
Why?
Pregnancy
5
2023
3286
0.140
Why?
Diabetes Mellitus
2
2023
815
0.140
Why?
Blood Platelets
9
1988
153
0.130
Why?
Translating
1
2017
17
0.130
Why?
Clothing
3
1988
7
0.130
Why?
Models, Cardiovascular
1
2018
97
0.130
Why?
Cholangiography
4
1994
38
0.130
Why?
Cohort Studies
6
2019
3242
0.130
Why?
Primary Prevention
1
2018
93
0.130
Why?
Long-Term Care
2
2011
69
0.120
Why?
Oxygen
3
2001
777
0.120
Why?
Polysaccharides
2
2007
101
0.120
Why?
Precision Medicine
2
2019
512
0.120
Why?
Cholelithiasis
4
1994
36
0.120
Why?
Follow-Up Studies
10
2005
4049
0.120
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
2
2007
28
0.120
Why?
Acute Disease
7
2008
864
0.120
Why?
Prothrombin Time
8
2018
18
0.120
Why?
Inflammatory Bowel Diseases
1
2023
685
0.110
Why?
Upper Extremity
1
2016
70
0.110
Why?
Abdominal Muscles
2
1995
26
0.110
Why?
Cardiac Surgical Procedures
2
2017
511
0.110
Why?
Dihydroergotamine
1
1995
1
0.110
Why?
Factor V
2
2005
10
0.110
Why?
Gallstones
2
1988
21
0.110
Why?
Risk
2
2017
662
0.110
Why?
Tourniquets
1
1994
10
0.110
Why?
Tissue Adhesions
1
1995
55
0.110
Why?
Dose-Response Relationship, Drug
3
2008
1949
0.110
Why?
Platelet Activation
1
2014
18
0.110
Why?
Antithrombins
1
2014
20
0.100
Why?
Varicose Ulcer
1
2014
6
0.100
Why?
Vitamin K
1
2014
27
0.100
Why?
Survival Analysis
4
2017
1530
0.100
Why?
Inpatients
2
2016
371
0.100
Why?
Elasticity
3
2010
98
0.100
Why?
Double-Blind Method
4
2015
1793
0.100
Why?
Health Services Research
2
2005
146
0.100
Why?
Cost-Benefit Analysis
5
2013
521
0.090
Why?
Clinical Protocols
3
2015
156
0.090
Why?
Hemodynamics
2
2016
749
0.090
Why?
Partial Thromboplastin Time
6
1999
17
0.090
Why?
Cardiopulmonary Bypass
2
1995
162
0.090
Why?
Drug Therapy, Combination
3
2012
766
0.090
Why?
Acute Coronary Syndrome
1
2012
31
0.090
Why?
Drug Interactions
1
2012
240
0.090
Why?
Hemostasis
2
1995
24
0.080
Why?
Fibrinolysin
3
1988
25
0.080
Why?
Biliary Tract
1
1991
12
0.080
Why?
Europe
3
2008
360
0.080
Why?
Awareness
2
2009
93
0.080
Why?
Iatrogenic Disease
1
1991
71
0.080
Why?
Blood Coagulation Tests
7
1985
31
0.080
Why?
Young Adult
2
2021
7598
0.080
Why?
Prognosis
8
2017
4139
0.080
Why?
Validation Studies as Topic
1
2010
20
0.080
Why?
Algorithms
1
2018
2005
0.080
Why?
Neurosurgical Procedures
1
2014
404
0.080
Why?
Blood Coagulation Factors
4
2004
20
0.070
Why?
Intraoperative Complications
3
1995
195
0.070
Why?
Case-Control Studies
3
2005
2017
0.070
Why?
Probability
2
2008
356
0.070
Why?
Plasminogen Activators
2
1996
10
0.070
Why?
Pulmonary Veins
2
2020
119
0.070
Why?
Randomized Controlled Trials as Topic
2
2010
995
0.070
Why?
Posture
3
2006
124
0.070
Why?
Meta-Analysis as Topic
1
2008
87
0.070
Why?
Drug Evaluation
1
2008
109
0.070
Why?
Reproducibility of Results
3
2020
2799
0.070
Why?
Consensus
2
2020
308
0.070
Why?
Arthroplasty, Replacement
1
2008
34
0.070
Why?
North America
1
2008
211
0.070
Why?
Dogs
10
1995
642
0.060
Why?
Health Promotion
1
2009
175
0.060
Why?
Ferrosoferric Oxide
1
2007
19
0.060
Why?
Health Policy
1
2009
218
0.060
Why?
Streptokinase
1
1986
10
0.060
Why?
Statistics, Nonparametric
2
2005
304
0.060
Why?
Pneumoperitoneum, Artificial
2
1994
8
0.060
Why?
Patient Outcome Assessment
2
2017
90
0.060
Why?
Animals
17
2013
29045
0.060
Why?
Combined Modality Therapy
4
2011
1754
0.060
Why?
Surgical Instruments
2
1985
70
0.060
Why?
Catheterization
5
1994
220
0.060
Why?
Length of Stay
2
2016
889
0.060
Why?
Societies, Medical
2
2008
687
0.060
Why?
Reference Standards
3
1995
147
0.060
Why?
Internationality
2
2019
80
0.060
Why?
Models, Statistical
1
2010
602
0.060
Why?
Survival Rate
2
2012
2057
0.060
Why?
Blood Circulation
1
2005
29
0.060
Why?
Canada
2
2017
210
0.060
Why?
Elastic Tissue
1
2005
18
0.060
Why?
Blood Coagulation Factor Inhibitors
1
2005
4
0.060
Why?
Multivariate Analysis
2
2019
1007
0.060
Why?
Protein Tyrosine Phosphatases
1
2005
48
0.060
Why?
Comorbidity
1
2009
1037
0.060
Why?
Monte Carlo Method
2
2003
194
0.060
Why?
Guidelines as Topic
1
2006
169
0.060
Why?
Aftercare
1
2006
93
0.060
Why?
Catheters
2
2016
109
0.050
Why?
Blood Specimen Collection
2
1995
29
0.050
Why?
BCG Vaccine
3
1984
44
0.050
Why?
Arteries
1
2005
172
0.050
Why?
Genetic Markers
1
2005
471
0.050
Why?
Monocytes
1
2005
219
0.050
Why?
Receptors, Cell Surface
1
2005
291
0.050
Why?
Antiphospholipid Syndrome
1
2004
17
0.050
Why?
Image Enhancement
1
2007
503
0.050
Why?
Perfusion
1
2005
272
0.050
Why?
Professional Practice
1
2003
44
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2005
405
0.050
Why?
Plasminogen
6
1988
45
0.050
Why?
Models, Econometric
1
2003
15
0.050
Why?
Mutation
2
2005
4443
0.050
Why?
Sensitivity and Specificity
2
2007
1946
0.050
Why?
Life Expectancy
1
2003
93
0.050
Why?
Cost Savings
1
2003
69
0.050
Why?
Neoplasm Metastasis
3
2005
1102
0.050
Why?
Breast Neoplasms
7
2005
3303
0.050
Why?
Markov Chains
1
2003
155
0.050
Why?
Models, Economic
1
2002
72
0.050
Why?
Interviews as Topic
1
2003
390
0.040
Why?
Quality-Adjusted Life Years
1
2003
170
0.040
Why?
Plethysmography
1
2001
17
0.040
Why?
Home Care Services, Hospital-Based
1
2001
10
0.040
Why?
Odds Ratio
3
2011
728
0.040
Why?
Foot
1
2001
64
0.040
Why?
Cholangiopancreatography, Endoscopic Retrograde
2
1994
73
0.040
Why?
Computers
2
1979
103
0.040
Why?
Disseminated Intravascular Coagulation
4
1995
29
0.040
Why?
Health Care Surveys
1
2002
282
0.040
Why?
Peptide Hydrolases
2
1988
99
0.040
Why?
Hematocrit
7
1988
68
0.040
Why?
Genetic Testing
1
2005
610
0.040
Why?
Adolescent
6
2019
10168
0.040
Why?
Drug Combinations
2
1995
202
0.040
Why?
Common Bile Duct
1
1980
19
0.040
Why?
Gallbladder Diseases
1
1980
21
0.040
Why?
Peritoneum
1
1980
52
0.040
Why?
Medication Therapy Management
1
2020
19
0.040
Why?
Postoperative Period
2
1999
325
0.040
Why?
Drug Therapy, Computer-Assisted
1
1999
9
0.040
Why?
Ultrasonography, Doppler, Pulsed
1
1999
5
0.040
Why?
Prostatic Neoplasms
2
2003
1846
0.040
Why?
Pulmonary Medicine
1
2000
52
0.040
Why?
Pressure
2
1994
173
0.040
Why?
Serine Proteinase Inhibitors
2
1996
25
0.040
Why?
Immunoassay
1
1999
102
0.040
Why?
Dextrans
1
1979
77
0.040
Why?
Blood Sedimentation
1
2018
13
0.040
Why?
Puerperal Disorders
1
1979
36
0.040
Why?
Burns
2
1978
150
0.030
Why?
Lipoproteins
2
1996
136
0.030
Why?
Diatomaceous Earth
2
1995
3
0.030
Why?
Operating Room Nursing
1
1978
1
0.030
Why?
Hernia, Ventral
1
1978
31
0.030
Why?
Data Display
1
1978
19
0.030
Why?
Electronics
1
1978
21
0.030
Why?
Bayes Theorem
1
1999
423
0.030
Why?
Vena Cava, Inferior
1
1979
140
0.030
Why?
China
1
2018
283
0.030
Why?
Endothelium, Vascular
1
2020
440
0.030
Why?
Ovary
1
1979
262
0.030
Why?
Lung Diseases
1
2020
284
0.030
Why?
Popliteal Vein
3
1995
4
0.030
Why?
Preoperative Care
3
1995
420
0.030
Why?
Fibrin
2
1995
86
0.030
Why?
Mastectomy
2
1980
277
0.030
Why?
Clinical Decision-Making
1
2019
306
0.030
Why?
Cross-Sectional Studies
1
2023
2077
0.030
Why?
Calcium
3
1995
1205
0.030
Why?
Hemostatics
2
1974
63
0.030
Why?
Platelet Count
4
1995
94
0.030
Why?
Intestinal Obstruction
1
1997
99
0.030
Why?
Endothelins
1
1995
26
0.030
Why?
Thrombolytic Therapy
3
2007
261
0.030
Why?
Hypoxia
1
2001
685
0.030
Why?
Regional Blood Flow
1
2016
194
0.030
Why?
Logistic Models
1
2019
1276
0.030
Why?
Platelet Transfusion
1
1995
14
0.030
Why?
Blood Transfusion, Autologous
1
1995
18
0.030
Why?
Electronic Health Records
1
2020
456
0.030
Why?
Treatment Failure
1
2015
300
0.030
Why?
False Negative Reactions
1
1995
59
0.030
Why?
Indicators and Reagents
1
1995
68
0.030
Why?
Documentation
1
2016
114
0.030
Why?
Intestine, Small
1
1997
321
0.030
Why?
Magnetic Resonance Imaging
1
2007
3622
0.030
Why?
Rabbits
2
1995
582
0.030
Why?
Walking
1
2016
114
0.030
Why?
Transplantation
1
1995
39
0.030
Why?
False Positive Reactions
1
1995
214
0.030
Why?
Cell Adhesion
2
2005
421
0.030
Why?
Disposable Equipment
1
1994
25
0.030
Why?
Pressure Ulcer
1
2014
45
0.020
Why?
Infant, Newborn
2
2019
2556
0.020
Why?
Cause of Death
2
2005
279
0.020
Why?
Age Factors
1
2018
1976
0.020
Why?
Fibrinogen
6
1987
48
0.020
Why?
Artifacts
1
1995
248
0.020
Why?
Academic Medical Centers
1
2016
416
0.020
Why?
Research Design
1
2017
652
0.020
Why?
Remission Induction
1
1995
764
0.020
Why?
Diagnosis, Computer-Assisted
1
1995
338
0.020
Why?
Infant
1
2019
3368
0.020
Why?
In Vitro Techniques
4
2005
945
0.020
Why?
Wound Healing
1
2014
385
0.020
Why?
Child, Preschool
1
2019
4053
0.020
Why?
Biliary Tract Surgical Procedures
1
1991
14
0.020
Why?
Biliary Fistula
1
1991
12
0.020
Why?
Rupture
1
1991
59
0.020
Why?
Duodenal Diseases
1
1991
26
0.020
Why?
Intestinal Fistula
1
1991
32
0.020
Why?
Stroke
1
2020
1163
0.020
Why?
Wounds, Penetrating
1
1991
68
0.020
Why?
Infusions, Parenteral
2
1983
47
0.020
Why?
Radiography
2
1991
763
0.020
Why?
Platelet Aggregation
2
1988
40
0.020
Why?
Drug-Related Side Effects and Adverse Reactions
1
2012
220
0.020
Why?
Program Development
1
2010
141
0.020
Why?
Delivery of Health Care, Integrated
1
2010
72
0.020
Why?
Chi-Square Distribution
1
2010
361
0.020
Why?
Thromboplastin
2
2007
8
0.020
Why?
Controlled Clinical Trials as Topic
1
2008
20
0.020
Why?
Intubation
1
1988
21
0.020
Why?
Clinical Trials, Phase III as Topic
1
2009
172
0.020
Why?
alpha-2-Antiplasmin
1
1988
6
0.020
Why?
Antithrombin III
1
1988
9
0.020
Why?
Argentina
1
2008
15
0.020
Why?
Israel
1
2008
69
0.020
Why?
Vena Cava Filters
2
2003
92
0.020
Why?
Laparoscopy
1
1995
800
0.020
Why?
Sex Distribution
1
2008
176
0.020
Why?
Fluoroscopy
1
1988
139
0.020
Why?
Age Distribution
1
2008
211
0.020
Why?
Hematoma
3
1977
106
0.020
Why?
Rats
2
2005
4079
0.020
Why?
Neoplasm Recurrence, Local
4
1984
1538
0.020
Why?
Patient Care Team
1
2010
318
0.020
Why?
Child
1
2019
7771
0.020
Why?
Statistics as Topic
4
1981
229
0.020
Why?
P-Selectin
1
2007
14
0.020
Why?
Placebos
1
2007
210
0.020
Why?
Melphalan
3
1984
98
0.020
Why?
Population Surveillance
1
2008
218
0.020
Why?
Caseins
1
1986
9
0.020
Why?
Plasma
3
1995
49
0.020
Why?
Urokinase-Type Plasminogen Activator
1
1986
49
0.020
Why?
Factor XII
2
1977
2
0.010
Why?
Textiles
1
2006
2
0.010
Why?
Random Allocation
2
1984
312
0.010
Why?
Thrombectomy
1
2008
265
0.010
Why?
Decision Making
1
1991
691
0.010
Why?
Education, Medical, Graduate
1
2010
455
0.010
Why?
Umbilical Veins
1
2005
45
0.010
Why?
Calibration
1
2006
109
0.010
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 6
1
2005
16
0.010
Why?
Knee Joint
2
1977
181
0.010
Why?
Protein Phosphatase 1
1
2005
31
0.010
Why?
Quality Control
1
2006
131
0.010
Why?
Blood Vessels
1
1985
93
0.010
Why?
Patient Education as Topic
1
2009
419
0.010
Why?
Databases as Topic
1
2005
96
0.010
Why?
Chronic Disease
1
2008
991
0.010
Why?
Angiogenesis Inhibitors
1
2007
281
0.010
Why?
Aircraft
1
2005
26
0.010
Why?
Autopsy
1
2005
131
0.010
Why?
Immobilization
1
2004
21
0.010
Why?
Membrane Glycoproteins
1
2007
446
0.010
Why?
Leukocytes
1
2005
214
0.010
Why?
Reference Values
2
1995
608
0.010
Why?
Biomechanical Phenomena
1
2006
517
0.010
Why?
Nematode Infections
1
1983
4
0.010
Why?
Eosinophilic Granuloma
1
1983
9
0.010
Why?
Spain
1
2003
36
0.010
Why?
RNA, Small Interfering
1
2005
573
0.010
Why?
Adjuvants, Immunologic
1
1984
177
0.010
Why?
Omentum
1
1983
69
0.010
Why?
Ischemia
1
2005
263
0.010
Why?
Phosphorylation
1
2005
1148
0.010
Why?
Appendicitis
1
1983
72
0.010
Why?
Rats, Sprague-Dawley
1
2005
1256
0.010
Why?
Kidney Failure, Chronic
1
1987
451
0.010
Why?
Contrast Media
1
2007
1014
0.010
Why?
Amino Acids
1
2003
248
0.010
Why?
Drug Costs
1
2002
66
0.010
Why?
Secondary Prevention
1
2002
194
0.010
Why?
Interleukin-6
1
2003
283
0.010
Why?
Complement C4
2
1980
9
0.010
Why?
Vascular Endothelial Growth Factor A
1
2003
402
0.010
Why?
Complement C3
2
1980
63
0.010
Why?
Cholecystitis
1
1980
17
0.010
Why?
Methods
1
1980
134
0.010
Why?
Injections
2
1979
131
0.010
Why?
L-Lactate Dehydrogenase
1
1980
71
0.010
Why?
Aspartate Aminotransferases
1
1980
74
0.010
Why?
Kallikreins
2
1978
47
0.010
Why?
Jugular Veins
1
1980
65
0.010
Why?
Therapeutic Irrigation
1
1980
77
0.010
Why?
Microscopy
1
1980
92
0.010
Why?
Antineoplastic Agents
2
1982
2386
0.010
Why?
Leukemia
1
1982
310
0.010
Why?
Drainage
1
1980
176
0.010
Why?
Transplantation, Autologous
1
1980
398
0.010
Why?
Cell Line, Tumor
1
2005
2913
0.010
Why?
Infant, Newborn, Diseases
1
1980
94
0.010
Why?
Blood Viscosity
1
1979
14
0.010
Why?
Neoplasm Staging
2
1984
2087
0.010
Why?
Viscosity
1
1979
52
0.010
Why?
Injections, Intravenous
2
1995
215
0.010
Why?
Operating Room Technicians
1
1978
1
0.010
Why?
Analog-Digital Conversion
1
1978
8
0.010
Why?
Kaolin
1
1977
9
0.010
Why?
Sodium
1
1979
332
0.010
Why?
Blood Cell Count
4
1979
67
0.010
Why?
Punctures
1
1977
29
0.010
Why?
Equipment and Supplies
1
1977
32
0.010
Why?
Respiratory Insufficiency
1
1980
205
0.010
Why?
Endoscopy
1
1980
388
0.010
Why?
Renal Dialysis
2
1987
357
0.010
Why?
Cattle
2
1974
398
0.010
Why?
Fatal Outcome
1
1997
295
0.010
Why?
Cysts
1
1977
100
0.010
Why?
Plasminogen Activator Inhibitor 1
1
1996
46
0.010
Why?
Radioimmunoassay
1
1995
139
0.010
Why?
Prevalence
1
2000
1396
0.010
Why?
Heparin Antagonists
1
1975
3
0.010
Why?
Blood Cells
1
1975
32
0.010
Why?
Illinois
1
1977
531
0.010
Why?
Hysterectomy
1
1997
175
0.010
Why?
Patient Satisfaction
1
1999
519
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
1995
374
0.010
Why?
Esterases
1
1974
13
0.010
Why?
Tissue Plasminogen Activator
1
1996
180
0.010
Why?
Silicon Dioxide
1
1974
40
0.010
Why?
Neoplasms, Experimental
1
1976
263
0.010
Why?
Factor XIII
1
1974
5
0.010
Why?
Calcium Chloride
1
1974
11
0.010
Why?
Venoms
1
1974
11
0.010
Why?
Urea
1
1974
54
0.010
Why?
Edetic Acid
1
1974
40
0.010
Why?
Lymph Node Excision
1
1975
238
0.010
Why?
Solubility
1
1974
187
0.010
Why?
Observer Variation
1
1995
579
0.010
Why?
Heart-Lung Machine
1
1973
5
0.010
Why?
Analysis of Variance
1
1995
890
0.010
Why?
Intrinsic Factor
1
1972
1
0.010
Why?
Hemophilia B
1
1972
5
0.010
Why?
Hemophilia A
1
1972
6
0.010
Why?
Membranes, Artificial
1
1973
39
0.010
Why?
Temperature
1
1974
446
0.010
Why?
Cyclophosphamide
2
1984
285
0.010
Why?
Abortion, Septic
1
1972
3
0.010
Why?
Muscles
1
1973
179
0.010
Why?
Blood Platelet Disorders
1
1972
13
0.010
Why?
Menstruation Disturbances
1
1972
22
0.010
Why?
Ligation
1
1972
55
0.010
Why?
Intraoperative Period
1
1991
93
0.010
Why?
Fluorouracil
2
1984
543
0.010
Why?
Diagnosis, Differential
3
1983
1571
0.010
Why?
Obesity
1
1978
1079
0.010
Why?
Kinetics
3
1979
1478
0.010
Why?
Physicians
1
1978
687
0.000
Why?
Causality
1
1991
86
0.000
Why?
Gastrointestinal Diseases
1
1972
156
0.000
Why?
Necrosis
2
1983
225
0.000
Why?
Gastrointestinal Hemorrhage
1
1972
251
0.000
Why?
Tissue Distribution
1
1988
290
0.000
Why?
Endopeptidases
1
1988
114
0.000
Why?
Uremia
1
1987
14
0.000
Why?
Hemoglobins
2
1980
197
0.000
Why?
Prednisolone
1
1984
38
0.000
Why?
Doxorubicin
1
1984
285
0.000
Why?
Larva
1
1983
139
0.000
Why?
Carbon Dioxide
2
1973
202
0.000
Why?
Hydrogen-Ion Concentration
2
1973
489
0.000
Why?
Prednisone
1
1982
252
0.000
Why?
Hyaline Membrane Disease
1
1980
3
0.000
Why?
Whole Blood Coagulation Time
1
1979
7
0.000
Why?
Erythrocyte Count
1
1978
21
0.000
Why?
Complement System Proteins
1
1978
87
0.000
Why?
Physical Examination
1
1979
149
0.000
Why?
Synovial Cyst
1
1977
17
0.000
Why?
Mathematics
1
1977
176
0.000
Why?
Popliteal Artery
1
1977
32
0.000
Why?
Joint Diseases
1
1977
48
0.000
Why?
Bone Neoplasms
1
1979
316
0.000
Why?
Elastin
1
1976
8
0.000
Why?
Dimethylpolysiloxanes
1
1976
12
0.000
Why?
Surface Properties
1
1976
130
0.000
Why?
Neutralization Tests
1
1975
74
0.000
Why?
Erythrocytes
1
1975
242
0.000
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1984
2666
0.000
Why?
Oxygenators, Membrane
1
1973
3
0.000
Why?
Hyperventilation
1
1973
12
0.000
Why?
Partial Pressure
1
1973
46
0.000
Why?
Extracorporeal Circulation
1
1973
37
0.000
Why?
Blood
1
1973
68
0.000
Why?
Hypercapnia
1
1973
50
0.000
Why?
Microelectrodes
1
1973
88
0.000
Why?
Brain Neoplasms
1
1979
845
0.000
Why?
Intestinal Mucosa
1
1977
846
0.000
Why?
Femoral Artery
1
1973
96
0.000
Why?
Liver Neoplasms
1
1979
840
0.000
Why?
Lung
1
1977
1409
0.000
Why?
Models, Biological
1
1977
1806
0.000
Why?
Heart Rate
1
1973
534
0.000
Why?
Electrocardiography
1
1973
528
0.000
Why?
Disease Models, Animal
1
1976
2581
0.000
Why?
Lung Neoplasms
1
1979
2474
0.000
Why?
Caprini's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (551)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_